Cite
Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain.
MLA
Polepalli, Sravani, et al. “Role of UHRF1 in Malignancy and Its Function as a Therapeutic Target for Molecular Docking towards the SRA Domain.” International Journal of Biochemistry & Cell Biology, vol. 114, Sept. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biocel.2019.06.006.
APA
Polepalli, S., George, S. M., Valli Sri Vidya, R., Rodrigues, G. S., Ramachandra, L., Chandrashekar, R., M, D. N., Rao, P. P. N., Pestell, R. G., & Rao, M. (2019). Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. International Journal of Biochemistry & Cell Biology, 114, N.PAG. https://doi.org/10.1016/j.biocel.2019.06.006
Chicago
Polepalli, Sravani, Sophia M George, R Valli Sri Vidya, Gabriel Sunil Rodrigues, L. Ramachandra, Raghu Chandrashekar, Deepak Nayak M, Praveen P.N. Rao, Richard G. Pestell, and Mahadev Rao. 2019. “Role of UHRF1 in Malignancy and Its Function as a Therapeutic Target for Molecular Docking towards the SRA Domain.” International Journal of Biochemistry & Cell Biology 114 (September): N.PAG. doi:10.1016/j.biocel.2019.06.006.